Fig. 7: CDK8 controls metastatic properties of TNBC cells and drives NK-cell immune evasion.

CDK8 in TNBC drives invasion and metastatic dissemination of tumor cells and immune evasion (left box). Loss of CDK8 in tumor cells on the one hand, dampens invasiveness and pro-metastatic behavior of tumor cells and on the other hand, enhances recognition by NK cells, thereby decreasing tumor burden (right box).